Covid-19: Brazil regulator to decide on emergency use of Sinovac, AstraZeneca vaccines | World News - Hindustan Times
close_game
close_game

Covid-19: Brazil regulator to decide on emergency use of Sinovac, AstraZeneca vaccines

Reuters | , Brasilia/sao Paulo
Jan 17, 2021 09:37 PM IST

Adding to urgency for vaccinations, a second wave of the outbreak in Brazil is snowballing as the country confronts a new, potentially more contagious variant of the coronavirus.

Brazilian health regulator Anvisa on Sunday opened an extraordinary meeting of its board of directors to decide whether to approve emergency use of Covid-19 vaccines from China's Sinovac Biotech and Britain's AstraZeneca to begin immunizations as the pandemic enters a deadly second wave.

A worker holds a vial of the AstraZeneca Plc and the University of Oxford Covid-19 vaccine.(Bloomberg File Photo )
A worker holds a vial of the AstraZeneca Plc and the University of Oxford Covid-19 vaccine.(Bloomberg File Photo )

Anvisa's decision will be a simple majority vote of the board's five directors. The meeting started just after 10 a.m. local time (1300 GMT) and is expected to last about five hours.

Hindustan Times - your fastest source for breaking news! Read now.

President Jair Bolsonaro, a coronavirus skeptic who has refused to take a vaccine himself, is under growing pressure to start inoculations in Brazil, which has lost more than 200,000 to Covid-19 – the worst death toll outside the United States.

However, delays with vaccine shipments and testing results have held up vaccinations in the country, once a global leader in mass immunizations and now regional laggard after peers such as Chile and Mexico started giving shots last month.Bolsonaro's government was planning to kick off a national immunization program this week but is still waiting on shipments of the AstraZeneca vaccine at the center of its plans. That has added to public frustration and offered a political rival the chance to upstage the right-wing president.

Sao Paulo Governor Joao Doria, who oversees the Butantan biomedical center that partnered with Sinovac in Brazil, could start vaccinations in the state capital on Sunday if Anvisa approves emergency use of the Chinese shot, called CoronaVac, according to a person with knowledge of the plans.

Bolsonaro, who considers Doria a potential rival for his 2022 re-election efforts, has taunted the governor over CoronaVac's disappointing 50% efficacy in Brazilian trials, but the federal Health Ministry has agreed to acquire and distribute the shot for the national immunization drive.

Adding to urgency for vaccinations, a second wave of the outbreak in Brazil is snowballing as the country confronts a new, potentially more contagious variant of the coronavirus that originated in Amazonas and prompted Britain and Italy to bar entry to Brazilians.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now!

Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On